Choosing best treatment plans for mid-to-low rectal cancer
Part of Cancer, Digestive system clinical trials.
This trial studies how to choose the best treatment strategy for people with rectal cancer located in the middle to lower part of the rectum. It may help doctors match the right treatment plan to tumor location and your overall situation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a confirmed diagnosis of rectal cancer based on pathology (tissue test).
- Your rectal tumor is located within 12 cm below the anus.
- Your cancer has not spread to distant parts of the body.
- You do not have more than one primary colorectal (colon/rectal) cancer at the same time.
- You have no history of previous cancers (malignant tumors), if applicable to the study rules.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows real-world treatment of locally advanced rectal cancer (cancer that has grown into nearby tissues but hasn't spread to distant organs) in patients who receive chemotherapy and/or radiation before surgery. Researchers track how different treatment approaches work to help improve outcomes.
This trial tests whether people with early- to intermediate-stage low rectal cancer can avoid surgery if their tumor responds well to a full course of chemotherapy and radiation. It starts with brief chemotherapy, then adjusts treatment based on how much the tumor shrinks.
This trial tests a treatment plan involving radiation, chemotherapy, and an immunotherapy drug (a PD-1 inhibitor) for people with a specific type of high-risk rectal cancer. The goal is to see if this combination helps shrink the tumor before surgery.
This trial tests whether a computer model can help doctors predict how difficult the surgery will be, so they can choose the best surgical approach for removing middle to lower rectal cancer. It aims to make the operation safer and more effective for patients like you.
This trial tests whether a full course of chemotherapy and radiation before any surgery (called total neoadjuvant therapy) can help you avoid surgery and preserve your rectum. It is for people with a specific early stage of rectal cancer that has not spread.
This study looks at how doctors decide to treat enlarged lymph nodes in the pelvis for rectal cancer. It aims to help guide whether surgery should remove those lymph nodes, using MRI findings to improve outcomes.
Hear when a new Rectal Neoplasms trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.